In the third quarter, Generali Asset Management SPA SGR increased its position in MetLife by 35.0%, acquiring 7,272 additional shares to bring its total to 28,075 shares valued at $2,313,000 based on the latest SEC filing. Several smaller asset managers also adjusted their holdings: Quaker Wealth Management LLC expanded its stake by 198.2% to 333 shares, Salomon & Ludwin LLC raised its position by 95.4% to 422 shares, and True Wealth Design LLC boosted its holding by 564.1% to 425 shares. New entrants included Evolution Wealth Management Inc. and MTM Investment Management LLC, each establishing positions valued at approximately $35,000 and $37,000 respectively. Overall, institutional investors and hedge funds now account for 94.99% of MetLife’s outstanding shares.

A total of thirteen research firms have weighed in on MetLife, with two assigning Strong Buy ratings, nine issuing Buy ratings and two issuing Hold ratings, resulting in a consensus Buy recommendation. Morgan Stanley and Mizuho both set target prices at $101.00 and rated the company overweight and outperform respectively. Wells Fargo raised its objective from $92.00 to $94.00 while maintaining an overweight stance, and UBS Group trimmed its target slightly from $96.00 to $95.00 yet retained a buy rating. Weiss Ratings reiterated a buy (b-) rating in late December. The average price target across these reports stands at $95.73.

In its most recent quarter, MetLife reported earnings per share of $2.37, surpassing consensus analyst estimates by $0.07. Revenue for the period reached $12.46 billion, representing a 5.9% year-over-year decline and falling short of the $18.64 billion forecast. Profitability metrics included a net margin of 5.30% and a return on equity of 21.00%. The company’s debt-to-equity ratio remained moderate at 0.54, while liquidity measures showed a current ratio and quick ratio both at 0.18, reflecting the firm’s capital structure and working capital profile.

MetLife declared a quarterly dividend of $0.5675 per share, paid on December 9 to shareholders of record as of November 4. This distribution annualizes to $2.27 per share, yielding 2.8% and reflecting a payout ratio of 42.75%. The consistency of the dividend underscores the firm’s commitment to returning cash to investors while maintaining a balance between growth investments and shareholder distributions.